Gregory W. Schafer, a member of the Board of Directors of Capricor Therapeutics, Inc., has notified the company that he will not stand for re-election when his term on the Board expires at the company's 2016 Annual Meeting of Stockholders, which is scheduled for June 2, 2016. Mr. Schafer will continue to serve as a member of the Board, as the Chairman of the Audit Committee of the Board and as a member of the Nominating and Corporate Governance Committee of the Board until the Annual Meeting. Mr. Schafer's decision not to stand for re-election is not due to any disagreement with the Company on any of the Company's operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.1 USD | +1.84% | -3.02% | +24.74% |
May. 17 | Oppenheimer Initiates Capricor Therapeutics at Outperform Rating | MT |
May. 13 | Transcript : Capricor Therapeutics, Inc., Q1 2024 Earnings Call, May 13, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.74% | 193M | |
+9.83% | 115B | |
+10.80% | 105B | |
-10.84% | 22.71B | |
-1.08% | 21.83B | |
-10.46% | 18.18B | |
-41.92% | 16.52B | |
-15.11% | 16.01B | |
+6.62% | 14.14B | |
+17.53% | 10.71B |
- Stock Market
- Equities
- CAPR Stock
- News Capricor Therapeutics, Inc.
- Gregory W. Schafer Not Stand for Re-Election as Member of the Board of Directors of Capricor Therapeutics, Inc